» Articles » PMID: 32854596

The Total Prevalence of Diagnosed Diabetes and the Quality of Diabetes Care for the Adult Population in Salten, Norway

Overview
Publisher Sage Publications
Specialty Public Health
Date 2020 Aug 29
PMID 32854596
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

To assess the total prevalence of types 1 and 2 diabetes and to describe and compare cardiovascular risk factors, vascular complications and the quality of diabetes care in adults with types 1 and 2 diabetes in Salten, Norway. Cross-sectional study including all patients with diagnosed diabetes in primary and specialist care in Salten, 2014 (population 80,338). Differences in cardiovascular risk factors, prevalence of vascular complications and attained treatment targets between diabetes types were assessed using regression analyses. We identified 3091 cases of diabetes, giving a total prevalence in all age groups of 3.8%, 3.4% and 0.45% for types 2 and 1 diabetes, respectively. In the age group 30-89 years the prevalence of type 2 diabetes was 5.3%. Among 3027 adults aged 18 years and older with diabetes, 2713 (89.6%) had type 2 and 304 (10.0%) type 1 diabetes. The treatment target for haemoglobin A1c (⩽7.0%/53 mmol/mol) was reached in 61.1% and 22.5% of types 2 and 1 diabetes patients, respectively. After adjusting for age, sex and diabetes duration we found differences between patients with types 2 and 1 diabetes in mean haemoglobin A1c (7.1% vs. 7.5%, <0.001), blood pressure (136/78 mmHg vs. 131/74 mmHg, <0.001) and prevalence of coronary heart disease (23.1% vs. 15.8%, <0.001). The prevalence of diagnosed type 2 diabetes was slightly lower than anticipated. Glycaemic control was not satisfactory in the majority of patients with type 1 diabetes. Coronary heart disease was more prevalent in patients with type 2 diabetes.

Citing Articles

Clinically available predictors of obstructive sleep apnoea requiring treatment in type 2 diabetes patients in primary care.

Agholme J, Ahtola K, Toll E, Carlhall C, Henriksson P, Kechagias S Sci Rep. 2025; 15(1):8710.

PMID: 40082634 PMC: 11906869. DOI: 10.1038/s41598-025-93362-1.


Prevalence and associated factors of diabetes among adult populations of Hawassa town, southern Ethiopia: A community based cross-sectional study.

Belete G, Sithole H PLoS One. 2025; 20(1):e0318081.

PMID: 39883731 PMC: 11781642. DOI: 10.1371/journal.pone.0318081.


Prevalence of increased risk of type 2 diabetes in general practice: a cross-sectional study in Norway.

Riise H, Graue M, Igland J, Birkeland K, Kolltveit B BMC Prim Care. 2023; 24(1):151.

PMID: 37468831 PMC: 10357693. DOI: 10.1186/s12875-023-02100-x.


Level of education is associated with coronary heart disease and chronic kidney disease in individuals with type 2 diabetes: a population-based study.

Slatsve K, Claudi T, Lappegard K, Jenum A, Larsen M, Nokleby K BMJ Open Diabetes Res Care. 2022; 10(5).

PMID: 36171015 PMC: 9528574. DOI: 10.1136/bmjdrc-2022-002867.

References
1.
de Ferranti S, de Boer I, Fonseca V, Fox C, Golden S, Lavie C . Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation. 2014; 130(13):1110-30. DOI: 10.1161/CIR.0000000000000034. View

2.
Stene L, Midthjell K, Jenum A, Skeie S, Birkeland K, Lund E . [Prevalence of diabetes mellitus in Norway]. Tidsskr Nor Laegeforen. 2004; 124(11):1511-4. View

3.
Tancredi M, Rosengren A, Svensson A, Kosiborod M, Pivodic A, Gudbjornsdottir S . Excess Mortality among Persons with Type 2 Diabetes. N Engl J Med. 2015; 373(18):1720-32. DOI: 10.1056/NEJMoa1504347. View

4.
Ruiz P, Stene L, Bakken I, Haberg S, Birkeland K, Gulseth H . Decreasing incidence of pharmacologically and non-pharmacologically treated type 2 diabetes in Norway: a nationwide study. Diabetologia. 2018; 61(11):2310-2318. PMC: 6182655. DOI: 10.1007/s00125-018-4681-4. View

5.
. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387(10027):1513-1530. PMC: 5081106. DOI: 10.1016/S0140-6736(16)00618-8. View